While the survival rate for most cancers has improved dramatically, the survival rate for oral cancer has not changed significantly in over 30 years. You know that early detection of oral abnormalities is a key to survival – however, adjunctive screening technology is a key to early detection. ViziLite is the only FDA cleared medical device for use in the identification of oral abnormalities that could lead to cancer. ViziLite is a part of our practice’s oral cancer screening standard of care. For more information contact the Dr’s at 248.646.8651 or visit us at www.smilecreator.net.